Epigallocatechin-3-gallate alleviates trans, trans -2,4-decadienal-induced endothelial pyroptosis and dysfunction by inhibiting NLRP3 inflammasome activation
Journal of Functional Foods, ISSN: 1756-4646, Vol: 101, Page: 105428
2023
- 9Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures9
- Readers9
- Mentions1
- News Mentions1
- News1
Most Recent News
New Pyroptosis Study Findings Have Been Reported from Shenzhen University (Epigallocatechin-3-gallate alleviates trans, trans-2,4-decadienal-induced endothelial pyroptosis and dysfunction by inhibiting NLRP3 inflammasome activation)
2023 FEB 09 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Daily -- Researchers detail new data in pyroptosis. According to
Article Description
Trans, trans -2,4-decadienal (tt-DDE) is a highly reactive unsaturated aldehyde that widely present in foods. This study aimed to investigate the toxic effects of tt-DDE exposure on human umbilical vein endothelial cells (HUVECs) and the possible protective effects of green tea catechins. tt-DDE exposure induced pyroptosis and NLRP3 inflammasome activation in endothelial cells, as evidenced by increased LDH release and PI-positive cells, and elevated protein expressions of NLRP3, cleaved caspase-1, and GSDMD-N. NLRP3 inhibitor (MCC950) efficiently suppressed the tt-DDE-induced NLRP3 inflammasome activation and pyroptosis. Additionally, epigallocatechin-3-gallate (EGCG) showed the strongest activity among the four green tea catechins, which significantly alleviated tt-DDE-induced cytotoxicity. Moreover, EGCG effectively attenuated tt-DDE-induced endothelial cell pyroptosis and dysfunction by inhibiting NLRP3 inflammasome. Results of cultured mesenteric arteries further confirmed that EGCG prevented tt-DDE-induced endothelial dysfunction and pyroptosis. These results provide novel insights into tt-DDE-induced endothelial injury, and demonstrate the protective role of EGCG against tt-DDE-associated endothelial toxicity.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1756464623000282; http://dx.doi.org/10.1016/j.jff.2023.105428; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85147111436&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S1756464623000282; https://dx.doi.org/10.1016/j.jff.2023.105428
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know